{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T18:27:51Z","timestamp":1783103271108,"version":"3.54.6"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T00:00:00Z","timestamp":1510185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"},{"start":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T00:00:00Z","timestamp":1510185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1038\/bjc.2017.384","type":"journal-article","created":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T23:47:38Z","timestamp":1510271258000},"page":"98-105","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Prognostic impact and concordance of TERT promoter mutation and protein expression in matched primary and metastatic cutaneous melanoma"],"prefix":"10.1038","volume":"118","author":[{"given":"Emilia","family":"Hugdahl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May Britt","family":"Kalvenes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Mannelqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita G","family":"Ladstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars A","family":"Akslen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,9]]},"reference":[{"key":"BFbjc2017384_CR1","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1158\/2159-8290.CD-16-0177","volume":"6","author":"SC Akincilar","year":"2016","unstructured":"Akincilar SC, Khattar E, Boon PL, Unal B, Fullwood MJ, Tergaonkar V (2016) Long-range chromatin interactions drive mutant TERT promoter activation. Cancer Discov 6: 1276\u20131291.","journal-title":"Cancer Discov"},{"key":"BFbjc2017384_CR2","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1126\/science.aab0015","volume":"348","author":"RJ Bell","year":"2015","unstructured":"Bell RJ, Rube HT, Kreig A, Mancini A, Fouse SD, Nagarajan RP, Choi S, Hong C, He D, Pekmezci M, Wiencke JK, Wrensch MR, Chang SM, Walsh KM, Myong S, Song JS, Costello JF (2015) Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer. Science 348: 1036\u20131039.","journal-title":"Science"},{"key":"BFbjc2017384_CR3","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1097\/00000658-197011000-00017","volume":"172","author":"A Breslow","year":"1970","unstructured":"Breslow A (1970) Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 172: 902\u2013908.","journal-title":"Ann Surg"},{"key":"BFbjc2017384_CR4","first-page":"705","volume":"29","author":"WH Clark Jr.","year":"1969","unstructured":"Clark WH Jr., From L, Bernardino EA, Mihm MC (1969) The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 29: 705\u2013727.","journal-title":"Cancer Res"},{"key":"BFbjc2017384_CR5","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/pcmr.12500","volume":"29","author":"H Ekedahl","year":"2016","unstructured":"Ekedahl H, Lauss M, Olsson H, Griewank KG, Schadendorf D, Ingvar C, Jonsson G (2016) High TERT promoter mutation frequency in non-acral cutaneous metastatic melanoma. Pigment Cell Melanoma Res 29: 598\u2013600.","journal-title":"Pigment Cell Melanoma Res"},{"key":"BFbjc2017384_CR6","doi-asserted-by":"crossref","unstructured":"Griewank KG, Murali R, Puig-Butille JA, Schilling B, Livingstone E, Potrony M, Carrera C, Schimming T, Moller I, Schwamborn M, Sucker A, Hillen U, Badenas C, Malvehy J, Zimmer L, Scherag A, Puig S, Schadendorf D (2014) TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma. J Natl Cancer Inst 106.","DOI":"10.1093\/jnci\/dju246"},{"key":"BFbjc2017384_CR7","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144: 646\u2013674.","journal-title":"Cell"},{"key":"BFbjc2017384_CR8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nature22071","volume":"545","author":"NK Hayward","year":"2017","unstructured":"Hayward NK, Wilmott JS, Waddell N, Johansson PA, Field MA, Nones K, Patch AM, Kakavand H, Alexandrov LB, Burke H, Jakrot V, Kazakoff S, Holmes O, Leonard C, Sabarinathan R, Mularoni L, Wood S, Xu Q, Waddell N, Tembe V, Pupo GM, De Paoli-Iseppi R, Vilain RE, Shang P, Lau LMS, Dagg RA, Schramm SJ, Pritchard A, Dutton-Regester K, Newell F, Fitzgerald A, Shang CA, Grimmond SM, Pickett HA, Yang JY, Stretch JR, Behren A, Kefford RF, Hersey P, Long GV, Cebon J, Shackleton M, Spillane AJ, Saw RPM, Lopez-Bigas N, Pearson JV, Thompson JF, Scolyer RA, Mann GJ (2017) Whole-genome landscapes of major melanoma subtypes. Nature 545: 175\u2013180.","journal-title":"Nature"},{"key":"BFbjc2017384_CR9","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1038\/ncomms4401","volume":"5","author":"B Heidenreich","year":"2014","unstructured":"Heidenreich B, Nagore E, Rachakonda PS, Garcia-Casado Z, Requena C, Traves V, Becker J, Soufir N, Hemminki K, Kumar R (2014) Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma. Nat Commun 5: 3401.","journal-title":"Nat Commun"},{"key":"BFbjc2017384_CR10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.cell.2012.06.024","volume":"150","author":"E Hodis","year":"2012","unstructured":"Hodis E, Watson IR, Kryukov GV, Arold ST, Imielinski M, Theurillat JP, Nickerson E, Auclair D, Li L, Place C, Dicara D, Ramos AH, Lawrence MS, Cibulskis K, Sivachenko A, Voet D, Saksena G, Stransky N, Onofrio RC, Winckler W, Ardlie K, Wagle N, Wargo J, Chong K, Morton DL, Stemke-Hale K, Chen G, Noble M, Meyerson M, Ladbury JE, Davies MA, Gershenwald JE, Wagner SN, Hoon DS, Schadendorf D, Lander ES, Gabriel SB, Getz G, Garraway LA, Chin L (2012) A landscape of driver mutations in melanoma. Cell 150: 251\u2013263.","journal-title":"Cell"},{"key":"BFbjc2017384_CR11","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1126\/science.1230062","volume":"339","author":"S Horn","year":"2013","unstructured":"Horn S, Figl A, Rachakonda PS, Fischer C, Sucker A, Gast A, Kadel S, Moll I, Nagore E, Hemminki K, Schadendorf D, Kumar R (2013) TERT promoter mutations in familial and sporadic melanoma. Science 339: 959\u2013961.","journal-title":"Science"},{"key":"BFbjc2017384_CR12","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1126\/science.1229259","volume":"339","author":"FW Huang","year":"2013","unstructured":"Huang FW, Hodis E, Xu MJ, Kryukov GV, Chin L, Garraway LA (2013) Highly recurrent TERT promoter mutations in human melanoma. Science 339: 957\u2013959.","journal-title":"Science"},{"key":"BFbjc2017384_CR13","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/bjc.2016.44","volume":"114","author":"E Hugdahl","year":"2016","unstructured":"Hugdahl E, Kalvenes MB, Puntervoll HE, Ladstein RG, Akslen LA (2016) BRAF-V600E expression in primary nodular melanoma is associated with aggressive tumour features and reduced survival. Br J Cancer 114: 801\u2013808.","journal-title":"Br J Cancer"},{"key":"BFbjc2017384_CR14","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1097\/PAS.0b013e31802b3488","volume":"31","author":"TM Katona","year":"2007","unstructured":"Katona TM, Jones TD, Wang M, Eble JN, Billings SD, Cheng L (2007) Genetically heterogeneous and clonally unrelated metastases may arise in patients with cutaneous melanoma. Am J Surg Pathol 31: 1029\u20131037.","journal-title":"Am J Surg Pathol"},{"key":"BFbjc2017384_CR15","doi-asserted-by":"publisher","first-page":"6021","DOI":"10.1073\/pnas.1303607110","volume":"110","author":"PJ Killela","year":"2013","unstructured":"Killela PJ, Reitman ZJ, Jiao Y, Bettegowda C, Agrawal N, Diaz LA Jr., Friedman AH, Friedman H, Gallia GL, Giovanella BC, Grollman AP, He TC, He Y, Hruban RH, Jallo GI, Mandahl N, Meeker AK, Mertens F, Netto GJ, Rasheed BA, Riggins GJ, Rosenquist TA, Schiffman M, Shih IeM, Theodorescu D, Torbenson MS, Velculescu VE, Wang TL, Wentzensen N, Wood LD, Zhang M, Mclendon RE, Bigner DD, Kinzler KW, Vogelstein B, Papadopoulos N, Yan H (2013) TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci USA 110: 6021\u20136026.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbjc2017384_CR16","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/nm0798-844","volume":"4","author":"J Kononen","year":"1998","unstructured":"Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4: 844\u2013847.","journal-title":"Nat Med"},{"key":"BFbjc2017384_CR17","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/jid.2011.464","volume":"132","author":"RG Ladstein","year":"2012","unstructured":"Ladstein RG, Bachmann IM, Straume O, Akslen LA (2012a) Prognostic importance of the mitotic marker phosphohistone H3 in cutaneous nodular melanoma. J Invest Dermatol 132: 1247\u20131252.","journal-title":"J Invest Dermatol"},{"key":"BFbjc2017384_CR18","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1097\/PAS.0b013e31825a5b45","volume":"36","author":"RG Ladstein","year":"2012","unstructured":"Ladstein RG, Bachmann IM, Straume O, Akslen LA (2012b) Tumor necrosis is a prognostic factor in thick cutaneous melanoma. Am J Surg Pathol 36: 1477\u20131482.","journal-title":"Am J Surg Pathol"},{"key":"BFbjc2017384_CR19","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.2741\/1661","volume":"10","author":"SR Lai","year":"2005","unstructured":"Lai SR, Phipps SM, Liu L, Andrews LG, Tollefsbol TO (2005) Epigenetic control of telomerase and modes of telomere maintenance in aging and abnormal systems. Front Biosci 10: 1779\u20131796.","journal-title":"Front Biosci"},{"key":"BFbjc2017384_CR20","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/ncb3240","volume":"17","author":"Y Li","year":"2015","unstructured":"Li Y, Zhou QL, Sun W, Chandrasekharan P, Cheng HS, Ying Z, Lakshmanan M, Raju A, Tenen DG, Cheng SY, Chuang KH, Li J, Prabhakar S, Li M, Tergaonkar V (2015) Non-canonical NF-kappaB signalling and ETS1\/2 cooperatively drive C250T mutant TERT promoter activation. Nat Cell Biol 17: 1327\u20131338.","journal-title":"Nat Cell Biol"},{"key":"BFbjc2017384_CR21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00428-015-1784-x","volume":"467","author":"E Macerola","year":"2015","unstructured":"Macerola E, Loggini B, Giannini R, Garavello G, Giordano M, Proietti A, Niccoli C, Basolo F, Fontanini G (2015) Coexistence of TERT promoter and BRAF mutations in cutaneous melanoma is associated with more clinicopathological features of aggressiveness. Virchows Arch 467: 177\u2013184.","journal-title":"Virchows Arch"},{"issue":"1","key":"BFbjc2017384_CR22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/ijc.30042","volume":"139","author":"E Nagore","year":"2016","unstructured":"Nagore E, Heidenreich B, Rachakonda S, Garcia-Casado Z, Requena C, Soriano V, Frank C, Traves V, Quecedo E, Sanjuan-Gimenez J, Hemminki K, Teresa Landi M, Kumar R (2016a) TERT promoter mutations in melanoma survival. Int J Cancer. 139 (1): 75\u201384.","journal-title":"Int J Cancer."},{"key":"BFbjc2017384_CR23","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/pcmr.12441","volume":"29","author":"E Nagore","year":"2016","unstructured":"Nagore E, Heidenreich B, Requena C, Garcia-Casado Z, Martorell-Calatayud A, Pont-Sanjuan V, Jimenez-Sanchez AI, Kumar R (2016b) TERT promoter mutations associate with fast-growing melanoma. Pigment Cell Melanoma Res 29: 236\u2013238.","journal-title":"Pigment Cell Melanoma Res"},{"key":"BFbjc2017384_CR24","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/1096-9896(200107)194:3<349::AID-PATH887>3.0.CO;2-D","volume":"194","author":"A Nocito","year":"2001","unstructured":"Nocito A, Bubendorf L, Tinner EM, Suess K, Wagner U, Forster T, Kononen J, Fijan A, Bruderer J, Schmid U, Ackermann D, Maurer R, Alund G, Knonagel H, Rist M, Anabitarte M, Hering F, Hardmeier T, Schoenenberger AJ, Flury R, Jager P, Fehr JL, Schraml P, Moch H, Mihatsch MJ, Gasser T, Sauter G (2001) Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade. J Pathol 194: 349\u2013357.","journal-title":"J Pathol"},{"issue":"4","key":"BFbjc2017384_CR25","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00432-016-2322-1","volume":"143","author":"R Ofner","year":"2016","unstructured":"Ofner R, Ritter C, Heidenreich B, Kumar R, Ugurel S, Schrama D, Becker JC (2016) Distribution of TERT promoter mutations in primary and metastatic melanomas in Austrian patients. J Cancer Res Clin Oncol 143 (4): 613\u2013617.","journal-title":"J Cancer Res Clin Oncol"},{"key":"BFbjc2017384_CR26","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1038\/jid.2014.163","volume":"134","author":"H Populo","year":"2014","unstructured":"Populo H, Boaventura P, Vinagre J, Batista R, Mendes A, Caldas R, Pardal J, Azevedo F, Honavar M, Guimaraes I, Manuel Lopes J, Sobrinho-Simoes M, Soares P (2014) TERT promoter mutations in skin cancer: the effects of sun exposure and X-irradiation. J Invest Dermatol 134: 2251\u20132257.","journal-title":"J Invest Dermatol"},{"key":"BFbjc2017384_CR27","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1093\/nar\/gkl1125","volume":"35","author":"S Renaud","year":"2007","unstructured":"Renaud S, Loukinov D, Abdullaev Z, Guilleret I, Bosman FT, Lobanenkov V, Benhattar J (2007) Dual role of DNA methylation inside and outside of CTCF-binding regions in the transcriptional regulation of the telomerase hTERT gene. Nucleic Acids Res 35: 1245\u20131256.","journal-title":"Nucleic Acids Res"},{"key":"BFbjc2017384_CR28","doi-asserted-by":"publisher","first-page":"45704","DOI":"10.1038\/srep45704","volume":"7","author":"B Seynnaeve","year":"2017","unstructured":"Seynnaeve B, Lee S, Borah S, Park Y, Pappo A, Kirkwood JM, Bahrami A (2017) Genetic and epigenetic alterations of TERT are associated with inferior outcome in adolescent and young adult patients with melanoma. Sci Rep 7: 45704.","journal-title":"Sci Rep"},{"key":"BFbjc2017384_CR29","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1056\/NEJMoa1502583","volume":"373","author":"AH Shain","year":"2015","unstructured":"Shain AH, Yeh I, Kovalyshyn I, Sriharan A, Talevich E, Gagnon A, Dummer R, North J, Pincus L, Ruben B, Rickaby W, D'arrigo C, Robson A, Bastian BC (2015) The genetic evolution of melanoma from precursor lesions. N Engl J Med 373: 1926\u20131936.","journal-title":"N Engl J Med"},{"key":"BFbjc2017384_CR30","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1101\/gad.269498.115","volume":"29","author":"JL Stern","year":"2015","unstructured":"Stern JL, Theodorescu D, Vogelstein B, Papadopoulos N, Cech TR (2015) Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancers. Genes Dev 29: 2219\u20132224.","journal-title":"Genes Dev"},{"key":"BFbjc2017384_CR31","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/(SICI)1097-0215(19971021)74:5<535::AID-IJC10>3.0.CO;2-5","volume":"74","author":"O Straume","year":"1997","unstructured":"Straume O, Akslen LA (1997) Alterations and prognostic significance of p16 and p53 protein expression in subgroups of cutaneous melanoma. Int J Cancer 74: 535\u2013539.","journal-title":"Int J Cancer"},{"key":"BFbjc2017384_CR32","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/S0002-9440(10)64922-X","volume":"160","author":"O Straume","year":"2002","unstructured":"Straume O, Akslen LA (2002) Importance of vascular phenotype by basic fibroblast growth factor, and influence of the angiogenic factors basic fibroblast growth factor\/fibroblast growth factor receptor-1 and ephrin-A1\/EphA2 on melanoma progression. Am J Pathol 160: 1009\u20131019.","journal-title":"Am J Pathol"},{"key":"BFbjc2017384_CR33","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1038\/ncomms3185","volume":"4","author":"J Vinagre","year":"2013","unstructured":"Vinagre J, Almeida A, Populo H, Batista R, Lyra J, Pinto V, Coelho R, Celestino R, Prazeres H, Lima L, Melo M, Da Rocha AG, Preto A, Castro P, Castro L, Pardal F, Lopes JM, Santos LL, Reis RM, Cameselle-Teijeiro J, Sobrinho-Simoes M, Lima J, Maximo V, Soares P (2013) Frequency of TERT promoter mutations in human cancers. Nat Commun 4: 2185.","journal-title":"Nat Commun"},{"key":"BFbjc2017384_CR34","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.tig.2014.07.006","volume":"30","author":"MS Wong","year":"2014","unstructured":"Wong MS, Wright WE, Shay JW (2014) Alternative splicing regulation of telomerase: a new paradigm? Trends Genet 30: 430\u2013438.","journal-title":"Trends Genet"},{"key":"BFbjc2017384_CR35","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1242\/jcs.03001","volume":"119","author":"YL Wu","year":"2006","unstructured":"Wu YL, Dudognon C, Nguyen E, Hillion J, Pendino F, Tarkanyi I, Aradi J, Lanotte M, Tong JH, Chen GQ, Segal-Bendirdjian E (2006) Immunodetection of human telomerase reverse-transcriptase (hTERT) re-appraised: nucleolin and telomerase cross paths. J Cell Sci 119: 2797\u20132806.","journal-title":"J Cell Sci"},{"key":"BFbjc2017384_CR36","first-page":"513","volume":"12","author":"P Zygouris","year":"2007","unstructured":"Zygouris P, Tsiambas E, Tiniakos D, Karameris A, Athanassiou AE, Kittas C, Kyroudi A (2007) Evaluation of combined h-TERT, bcl-2, and caspases 3 and 8 expression in cutaneous malignant melanoma based on tissue microarrays and computerized image analysis. J BUON 12: 513\u2013519.","journal-title":"J BUON"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2017384.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2017384","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/bjc.2017.384","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2017384.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:40:14Z","timestamp":1684417214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2017384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,9]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["BFbjc2017384"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2017.384","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,9]]},"assertion":[{"value":"12 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2018","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}